NASDAQ:SIBN SiBone (SIBN) Stock Price, News & Analysis $16.39 -0.29 (-1.74%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$16.39 0.00 (-0.03%) As of 06/20/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About SiBone Stock (NASDAQ:SIBN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SiBone alerts:Sign Up Key Stats Today's Range$16.32▼$16.9950-Day Range$13.05▼$19.7952-Week Range$11.70▼$20.05Volume406,230 shsAverage Volume388,707 shsMarket Capitalization$698.54 millionP/E RatioN/ADividend YieldN/APrice Target$22.50Consensus RatingBuy Company OverviewSI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Read More… SiBone Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreSIBN MarketRank™: SiBone scored higher than 71% of companies evaluated by MarketBeat, and ranked 286th out of 926 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSiBone has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageSiBone has only been the subject of 3 research reports in the past 90 days.Read more about SiBone's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for SiBone are expected to grow in the coming year, from ($0.78) to ($0.59) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SiBone is -25.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SiBone is -25.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSiBone has a P/B Ratio of 4.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about SiBone's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.62% of the float of SiBone has been sold short.Short Interest Ratio / Days to CoverSiBone has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in SiBone has recently increased by 14.81%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSiBone does not currently pay a dividend.Dividend GrowthSiBone does not have a long track record of dividend growth. Sustainability and ESG3.3 / 5Environmental Score-1.44 Percentage of Shares Shorted4.62% of the float of SiBone has been sold short.Short Interest Ratio / Days to CoverSiBone has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in SiBone has recently increased by 14.81%, indicating that investor sentiment is decreasing significantly. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for SIBN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, SiBone insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,734,203.00 in company stock.Percentage Held by InsidersOnly 4.00% of the stock of SiBone is held by insiders.Percentage Held by Institutions98.11% of the stock of SiBone is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about SiBone's insider trading history. Receive SIBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SiBone and its competitors with MarketBeat's FREE daily newsletter. Email Address SIBN Stock News HeadlinesBrokers Issue Forecasts for SI-BONE FY2026 EarningsJune 13, 2025 | americanbankingnews.comSI-BONE to Truist Securities MedTech Conference on June 17, 2025June 4, 2025 | globenewswire.comRevealed: Steve Jobs' Secret Project Comes to Life on July 21st?Did Steve Jobs Leave Behind a $25 Trillion Gift for America? In his final years, America's greatest innovator worked on a secretive project beyond Apple's walls— a vision he believed would transform our nation's economy and restore its global leadership. Insiders called it "extraordinary" and "a model for improving America." On July 21st, this hidden legacy could finally be revealed, unlocking what CNBC calls a "$25 trillion opportunity" for generations to come.June 22, 2025 | InvestorPlace (Ad)SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025May 28, 2025 | globenewswire.comSI-BONE’s SWOT analysis: stock poised for growth amid market expansionMay 28, 2025 | investing.comEarnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their ForecastsMay 9, 2025 | finance.yahoo.comSI-BONE Inc. Q1 Loss Decreases, Beats EstimatesMay 7, 2025 | nasdaq.comSI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025May 6, 2025 | globenewswire.comSee More Headlines SIBN Stock Analysis - Frequently Asked Questions How have SIBN shares performed this year? SiBone's stock was trading at $14.02 at the beginning of the year. Since then, SIBN shares have increased by 16.9% and is now trading at $16.39. View the best growth stocks for 2025 here. How were SiBone's earnings last quarter? SiBone (NASDAQ:SIBN) issued its quarterly earnings data on Monday, May, 5th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.09. The firm earned $47.29 million during the quarter, compared to analyst estimates of $45.13 million. SiBone had a negative trailing twelve-month return on equity of 16.00% and a negative net margin of 15.03%. Read the conference call transcript. Does SiBone have any subsidiaries? SiBone subsidiaries include SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD. When did SiBone IPO? SiBone (SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. Who are SiBone's major shareholders? SiBone's top institutional shareholders include Brown Advisory Inc. (7.51%), American Century Companies Inc. (6.20%), Champlain Investment Partners LLC (6.09%) and Vanguard Group Inc. (5.75%). Insiders that own company stock include Laura Francis, Anthony J Recupero, Michael A Pisetsky, Anshul Maheshwari, John Gordon Freund, Timothy E Davis Jr and Mika Nishimura. View institutional ownership trends. How do I buy shares of SiBone? Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SiBone own? Based on aggregate information from My MarketBeat watchlists, some other companies that SiBone investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings5/05/2025Today6/21/2025Next Earnings (Estimated)8/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SIBN CIK1459839 Webwww.si-bone.com Phone(408) 207-0700FaxN/AEmployees350Year Founded2008Price Target and Rating Average Stock Price Target$22.50 High Stock Price Target$25.00 Low Stock Price Target$19.00 Potential Upside/Downside+37.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$30.91 million Net Margins-15.03% Pretax Margin-15.03% Return on Equity-16.00% Return on Assets-11.69% Debt Debt-to-Equity Ratio0.21 Current Ratio8.53 Quick Ratio7.26 Sales & Book Value Annual Sales$167.18 million Price / Sales4.18 Cash FlowN/A Price / Cash FlowN/A Book Value$3.98 per share Price / Book4.12Miscellaneous Outstanding Shares42,620,000Free Float40,910,000Market Cap$698.54 million OptionableOptionable Beta0.94 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:SIBN) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SiBone Please log in to your account or sign up in order to add this asset to your watchlist. Share SiBone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.